l carnitine tmao koeth 2013 nature medicine Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Gut Microbiota-Dependent Marker TMAO in
Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism Effects of choline metabolitetrimethylamine N oxide on immunometabolism in inflammatory bowel disease Frontiers Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link TMAO metaorganismal pathway and chronic inflammatory diseases The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect
Pay in 4 interest-free payments of $7.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
